313 related articles for article (PubMed ID: 25022375)
21. Prognostic Significance of Cyclins A2, B1, D1, and E1 and
Monteiro LS; Diniz-Freitas M; Warnakulasuriya S; Garcia-Caballero T; Forteza-Vila J; Fraga M
Anal Cell Pathol (Amst); 2018; 2018():7253510. PubMed ID: 29785357
[TBL] [Abstract][Full Text] [Related]
22. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
[TBL] [Abstract][Full Text] [Related]
23. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M
Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
[TBL] [Abstract][Full Text] [Related]
26. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.
Nazar M; Naz I; Mahmood MK; Hashmi SN
Asian Pac J Cancer Prev; 2020 Jan; 21(1):37-41. PubMed ID: 31983161
[TBL] [Abstract][Full Text] [Related]
28. FAS ligand expression in inflammatory infiltrate lymphoid cells as a prognostic marker in oral squamous cell carcinoma.
Peterle GT; Santos M; Mendes SO; Carvalho-Neto PB; Maia LL; Stur E; Agostini LP; Silva CV; Trivilin LO; Nunes FD; Carvalho MB; Tajara EH; Louro ID; Silva-Conforti AM
Genet Mol Res; 2015 Sep; 14(3):11145-53. PubMed ID: 26400345
[TBL] [Abstract][Full Text] [Related]
29. Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.
Williams M; Swampillai A; Osborne M; Mawdsley S; Hughes R; Harrison M; Harvey R; Glynne-Jones R;
Cancer; 2013 Jul; 119(13):2391-8. PubMed ID: 23576077
[TBL] [Abstract][Full Text] [Related]
30. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
31. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
[TBL] [Abstract][Full Text] [Related]
32. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
33. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
35. Four-protein signature accurately predicts lymph node metastasis and survival in oral squamous cell carcinoma.
Zanaruddin SN; Saleh A; Yang YH; Hamid S; Mustafa WM; Khairul Bariah AA; Zain RB; Lau SH; Cheong SC
Hum Pathol; 2013 Mar; 44(3):417-26. PubMed ID: 23026198
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
37. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
Formentini A; Henne-Bruns D; Kornmann M
Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
[TBL] [Abstract][Full Text] [Related]
38. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS
Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]